Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05LPP
|
|||
| Former ID |
DIB002613
|
|||
| Drug Name |
ABH001
|
|||
| Indication | Liver cancer [ICD-11: 2C12; ICD-10: C22] | Phase 3 | [1] | |
| Company |
Shire
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01749306) A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing. U.S. National Institutes ofHealth. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.